Concepts (104)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Career Choice | 4 | 2021 | 148 | 1.850 |
Why?
|
| Biomedical Research | 3 | 2021 | 405 | 1.340 |
Why?
|
| Students, Medical | 3 | 2017 | 425 | 1.140 |
Why?
|
| Education, Medical, Undergraduate | 2 | 2017 | 182 | 0.900 |
Why?
|
| Physicians | 3 | 2021 | 692 | 0.870 |
Why?
|
| Curriculum | 2 | 2017 | 573 | 0.820 |
Why?
|
| HMGB1 Protein | 2 | 2013 | 16 | 0.820 |
Why?
|
| Research Personnel | 1 | 2021 | 72 | 0.710 |
Why?
|
| Endothelial Cells | 2 | 2013 | 464 | 0.650 |
Why?
|
| Health Personnel | 1 | 2021 | 214 | 0.630 |
Why?
|
| Goals | 1 | 2017 | 67 | 0.550 |
Why?
|
| Attitude | 1 | 2016 | 130 | 0.490 |
Why?
|
| Internship and Residency | 3 | 2023 | 1062 | 0.450 |
Why?
|
| STAT3 Transcription Factor | 1 | 2013 | 86 | 0.440 |
Why?
|
| Capillary Permeability | 1 | 2010 | 132 | 0.340 |
Why?
|
| Cytoskeleton | 1 | 2010 | 195 | 0.330 |
Why?
|
| Pulmonary Artery | 1 | 2010 | 323 | 0.310 |
Why?
|
| Lung | 2 | 2013 | 1292 | 0.290 |
Why?
|
| Therapies, Investigational | 1 | 2005 | 17 | 0.250 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2005 | 52 | 0.240 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 1 | 2005 | 65 | 0.240 |
Why?
|
| Respiratory Insufficiency | 1 | 2005 | 162 | 0.210 |
Why?
|
| Medicine | 1 | 2023 | 91 | 0.200 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2005 | 191 | 0.200 |
Why?
|
| Neuroblastoma | 1 | 2005 | 400 | 0.180 |
Why?
|
| Schools, Medical | 2 | 2023 | 136 | 0.180 |
Why?
|
| Forecasting | 1 | 2021 | 304 | 0.170 |
Why?
|
| Lipopolysaccharides | 3 | 2013 | 295 | 0.150 |
Why?
|
| Cells, Cultured | 2 | 2013 | 2887 | 0.140 |
Why?
|
| Glutamine | 3 | 2001 | 79 | 0.140 |
Why?
|
| Professional Impairment | 1 | 2016 | 2 | 0.130 |
Why?
|
| Illness Behavior | 1 | 2016 | 7 | 0.130 |
Why?
|
| Humans | 11 | 2023 | 89968 | 0.130 |
Why?
|
| Occupational Health | 1 | 2016 | 36 | 0.130 |
Why?
|
| Heat-Shock Proteins | 2 | 2010 | 183 | 0.130 |
Why?
|
| Models, Biological | 2 | 2013 | 1765 | 0.120 |
Why?
|
| Adult | 4 | 2021 | 26822 | 0.120 |
Why?
|
| Male | 7 | 2021 | 42680 | 0.120 |
Why?
|
| Sex Factors | 1 | 2017 | 1075 | 0.110 |
Why?
|
| Ventilator-Induced Lung Injury | 1 | 2013 | 31 | 0.110 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 1083 | 0.110 |
Why?
|
| Microvessels | 1 | 2013 | 69 | 0.110 |
Why?
|
| Multiple Organ Failure | 1 | 2013 | 55 | 0.110 |
Why?
|
| United States | 3 | 2023 | 7108 | 0.110 |
Why?
|
| Stress, Mechanical | 1 | 2013 | 253 | 0.100 |
Why?
|
| Chicago | 1 | 2017 | 1434 | 0.100 |
Why?
|
| Female | 4 | 2021 | 46594 | 0.090 |
Why?
|
| Receptor for Advanced Glycation End Products | 1 | 2010 | 19 | 0.090 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2010 | 33 | 0.090 |
Why?
|
| Stress Fibers | 1 | 2010 | 24 | 0.090 |
Why?
|
| Attitude of Health Personnel | 1 | 2016 | 654 | 0.090 |
Why?
|
| Oxidative Stress | 1 | 2013 | 458 | 0.090 |
Why?
|
| Accreditation | 1 | 2011 | 61 | 0.090 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2010 | 125 | 0.090 |
Why?
|
| Electric Impedance | 1 | 2010 | 111 | 0.090 |
Why?
|
| Gap Junctions | 1 | 2010 | 144 | 0.090 |
Why?
|
| Molecular Chaperones | 1 | 2010 | 123 | 0.090 |
Why?
|
| Middle Aged | 2 | 2021 | 26148 | 0.090 |
Why?
|
| Cadherins | 1 | 2010 | 163 | 0.080 |
Why?
|
| Workload | 1 | 2011 | 129 | 0.080 |
Why?
|
| Gene Expression | 1 | 2013 | 1309 | 0.080 |
Why?
|
| Antigens, CD | 1 | 2010 | 466 | 0.080 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 557 | 0.080 |
Why?
|
| Actin Cytoskeleton | 1 | 2010 | 197 | 0.080 |
Why?
|
| Recombinant Proteins | 1 | 2010 | 1008 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 387 | 0.080 |
Why?
|
| Phosphorylation | 1 | 2010 | 1130 | 0.070 |
Why?
|
| Critical Care | 1 | 2011 | 384 | 0.070 |
Why?
|
| Actins | 1 | 2010 | 462 | 0.070 |
Why?
|
| Education, Medical, Graduate | 1 | 2011 | 402 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 586 | 0.070 |
Why?
|
| Pediatrics | 1 | 2011 | 360 | 0.070 |
Why?
|
| Parental Consent | 1 | 2005 | 35 | 0.060 |
Why?
|
| Licensure | 1 | 2023 | 6 | 0.050 |
Why?
|
| Critical Illness | 1 | 2005 | 311 | 0.050 |
Why?
|
| Endotoxemia | 1 | 2001 | 18 | 0.050 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2001 | 23 | 0.050 |
Why?
|
| Shock, Septic | 1 | 2001 | 105 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2010 | 3404 | 0.040 |
Why?
|
| Burns | 1 | 2001 | 142 | 0.040 |
Why?
|
| Decision Making | 1 | 2005 | 670 | 0.040 |
Why?
|
| Cytokines | 1 | 2001 | 811 | 0.040 |
Why?
|
| Surveys and Questionnaires | 1 | 2023 | 2655 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2005 | 8273 | 0.030 |
Why?
|
| Adolescent | 1 | 2005 | 9342 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2001 | 1237 | 0.020 |
Why?
|
| Rats | 2 | 2001 | 4048 | 0.020 |
Why?
|
| Burn Units | 1 | 2001 | 21 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2001 | 72 | 0.010 |
Why?
|
| Nutritional Status | 1 | 2001 | 81 | 0.010 |
Why?
|
| Endotoxins | 1 | 2001 | 36 | 0.010 |
Why?
|
| Ammonia | 1 | 2001 | 39 | 0.010 |
Why?
|
| Enteral Nutrition | 1 | 2001 | 105 | 0.010 |
Why?
|
| Ileum | 1 | 2001 | 168 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2001 | 155 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2001 | 192 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2001 | 607 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2001 | 700 | 0.010 |
Why?
|
| Sepsis | 1 | 2001 | 329 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2001 | 1714 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2001 | 1929 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2001 | 2393 | 0.010 |
Why?
|
| Time Factors | 1 | 2001 | 5359 | 0.010 |
Why?
|
| Animals | 2 | 2001 | 27528 | 0.010 |
Why?
|